Article Text

OP0033 European Scleroderma Study Group Activity Index Captures Variations in Disease Activity over Time and Predicts Organ Damage in Early Systemic Sclerosis: Data from The Canadian Scleroderma Research Group
  1. T. Nevskaya1,
  2. M. Baron2,
  3. J.E. Pope1,
  4. on behalf of Canadian Scleroderma Research Group
  1. 1Department of Medicine, Division of Rheumatology, University of Western Ontario, Schulich School of Medicine and Dentistry, London
  2. 2Division of Rheumatology, Jewish General Hospital, McGill University, Montreal, Canada


Background Endpoints in systemic sclerosis (SSc), such as modified Rodnan skin score (mRSS) and pulmonary function tests represent only parts of a multisystem disease. The European Scleroderma Study Group (EScSG) developed an SSc activity index, which captures involvement of multiple organs. The predictive validity of the SSc activity index is unclear.

Objectives To estimate the effect of disease activity as measured by EScSG activity index, on the risk of subsequent organ damage in the Canadian Scleroderma Research Group (CSRG) cohort.

Methods Of 421 SSc patients from the CSRG database with disease duration of ≤3 years, 197 who had no evidence of endstage organ damage initially and 3-year follow-up were included. Disease activity was assessed by EScSG activity index with two variability measures: 1. adjusted mean (am) EScSG activity score (the area under the curve of EScSG activity index over observation period), and 2. persistently active disease (PAD)/flare (EScSG score of ≥3 at follow-up visit). Internal organ involvement assessed over follow-up was based on Medsger severity scale and included accrual of a new severity score overall and by specific organ systems. Adjusted odds ratios (OR) for association between disease activity, severity and progression were calculated using regression analysis.

Results After adjustment for covariates, amEScSG activity score was the most consistent predictor of risk at 3 year follow-up: disease progression as accrual of a new severity grade (Δ≥1) in any of the major internal organs (OR 1.42, 95%CI 1.14–2.25, p=0.007), lung disease (OR 1.86, 95%CI 1.31–2.64, p<0.0001), decline in FVC (OR 3.05, 95%CI 1.47–6.31, p=0.003) and DLCO (OR 1.61, 95%CI 1.06–2.46, p=0.026), ΔHAQ (OR 1.729, 95%CI 1.250–2.391, p<0.001), severity of visceral disease (Table). amEScSG predicted accrual of organ damage only in diffuse cutaneous SSc (dcSSc). In the multivariable analysis, progression of lung disease in dcSSc was predicted by amEScSG activity score (p=0.006), and severity of lung disease by amEScSG (p<0.0001), older age (p=0.023), mRSS (p<0.001) and initial severity of lung disease (p<0.0001). The best predictor of renal disease severity at 3-year was initial severity of kidney involvement (p<0.0001).

Table 1.

Predictive value of EScSG activity index for a total severity score in cardiac, pulmonary and renal systems on Medsger's severity scale, at 1 and 3-year observation in regression analysis

Conclusions The mean adjusted EScSG reliably captured disease activity over time in individual patients and predicted the risk of deterioration in health status, disease progression and development of severe internal organ involvement in diffuse SSc, after adjustment for key covariates.

Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.